Regulation

TEVA Form 144 Filed on June 18 for Regulatory Compliance

Published on 6/19/2026

#TEVA#SEC#Regulation
TEVA Form 144 Filed on June 18 for Regulatory Compliance

AI Summary

Summarized by AI from the source below

On June 18, 2023, Teva Pharmaceutical Industries Ltd (TEVA) filed Form 144, which allows for the sale of restricted securities. This filing indicates potential stock transactions by insiders as required by SEC regulations. Such filings can impact market perception on TEVA's liquidity and shareholder structure. Monitoring these filings is important for investors seeking insights into the company's internal equity movements.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Indonesian Ferry Fire Leaves 5 Dead and Dozens Missing
Regulation

Indonesian Ferry Fire Leaves 5 Dead and Dozens Missing

Aug 3

Five Mohamed Al Fayed Survivors Confirmed as Trafficking Victims
Regulation

Five Mohamed Al Fayed Survivors Confirmed as Trafficking Victims

Aug 2

IQVIA (IQV) CEO Sold $26.1 Million Shares as Bookings Hit $3.15B
Markets

IQVIA (IQV) CEO Sold $26.1 Million Shares as Bookings Hit $3.15B

Aug 2

Uniroyal (UNR) Files for Chapter 11 Bankruptcy with $10M-$50M Assets
Regulation

Uniroyal (UNR) Files for Chapter 11 Bankruptcy with $10M-$50M Assets

Aug 2